Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice
1997

Effects of Amifostine on Carboplatin in Mice

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): AEC Korst, E Boven, MLT van der Sterre, AMJ Fichtinger-Schepman, WJF van der Vijgh

Primary Institution: University Hospital Vrije Universiteit

Hypothesis

Does amifostine enhance the efficacy of carboplatin in treating ovarian cancer in mice?

Conclusion

A single dose of amifostine increases the anti-tumour activity of carboplatin, while multiple doses may reduce its effectiveness due to hypothermia.

Supporting Evidence

  • A single dose of amifostine significantly increased the anti-tumour activity of carboplatin.
  • Three doses of amifostine resulted in less potentiation of carboplatin's efficacy due to hypothermia.
  • Amifostine did not affect the growth of tumours when given alone.

Takeaway

Amifostine helps make a cancer drug work better in mice, but giving it too many times can make it less effective.

Methodology

Mice with human ovarian cancer xenografts were treated with carboplatin alone or with one or three doses of amifostine, and the effects on tumour growth and drug levels were measured.

Limitations

The study was conducted in mice, which may not fully represent human responses.

Participant Demographics

Female athymic nude mice bearing human ovarian cancer xenografts.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication